Demographic details of infants in the fluticasone propionate (FP) and placebo groups
| FP(n = 17) | Placebo(n = 14) | |
|---|---|---|
| Values are shown as n (%) or *mean (95% CI). | ||
| RSV, respiratory syncytial virus; CMV, cytomegalovirus. | ||
| Sex (M/F) | 9/8 | 4/10 |
| Gestation (weeks) | 39.4 (38.6 to 40.1)* | 39.8 (38.9 to 40.7)* |
| Weight centile | 48.0 (32.3 to 63.7)* | 34.7 (18.3 to 51.2)* |
| Age (weeks) | 15.6 (10.2 to 21.0)* | 15.0 (10.2 to 19.8)* |
| Race | ||
| White | 15 (88.2%) | 14 (100%) |
| Others | 2 (11.8%) | 0 (0%) |
| Eczema on exam | 5 (17.6%) | 5 (35.7%) |
| Asthma in mother | 2 (11.8%) | 4 (28.6%) |
| Passive smoking | 10 (58.8%) | 7 (50.0%) |
| RSV | 8 (47.1%) | 6 (42.9%) |
| Other virus (CMV) | 1 (5.9%) | 0 (0%) |
| Days in hospital | 3.4 (2.4 to 4.3)* | 3.6 (2.4 to 4.8)* |